Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis-Reference-Cited by-同舟云学术

Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis

Published:2020-10-28 Issue:11 Volume:40 Page:2744-2757
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Culver Emma L.¹^ORCID,Bungay Helen K.²,Betts Margaret²,Forde Colm²³,Buchel Otto⁴,Manganis Charis¹,Warren Bryan F.⁵,Cummings Fraser R.¹⁶,Keshav Satish¹,Travis Simon P. L.¹,Chapman Roger W.¹

Affiliation:

1. Translational Gastroenterology Unit Nuffield Department of Medicine John Radcliffe HospitalUniversity of Oxford Oxford UK

2. Radiology Department John Radcliffe Hospital and Churchill Hospital Oxford UK

3. Radiology Department Queen Elizabeth Hospital Birmingham UK

4. Rondebosch Medical Centre Cape Town South Africa

5. Histopathology Department John Radcliffe Hospital Oxford UK

6. Gastroenterology Department Southampton General Hospital Southampton UK

Funder

NIHR Oxford Biomedical Research Centre

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14645

Reference41 articles.

1. Primary sclerosing cholangitis – a comprehensive review

2. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

3. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

4. MR Cholangiopancreatography in Patients with Primary Sclerosing Cholangitis: Interobserver Variability and Comparison with Endoscopic Retrograde Cholangiopancreatography

5. Recommendations on the use of magnetic resonance imaging in PSC‐A position statement from the International PSC Study Group

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of volatile organic compounds to diagnose primary sclerosing cholangitis;JHEP Reports;2024-08

2. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts;Gastroenterology;2024-06

3. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study;Alimentary Pharmacology & Therapeutics;2024-04-03

4. Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis;Clinics in Liver Disease;2024-02

5. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?;Journal of Hepatology;2024-01